Latest News
Juvenis CEO: 'We are pleased to execute a partnership with ChromaDex for the South Korean market'
By Karla Florez | Jun 11, 2022
ChromaDex Corp. has secured a partnership with Juvenis to launch cross-border sales in Tru Niagen, based in South Korea, a press release reported.
U.S. Global Investors: Returns of lockdowns in China 'a red flag for the global economy'
By David Beasley | Jun 9, 2022
Almost as soon as COVID-19 lockdowns were lifted in China June 1, they are already coming back.
Zwanziger: 'Our new tests deliver results in minutes from an easy-to-collect fingerstick sample, allowing fast and accurate management of cardiovascular conditions'
By John Kelly | Jun 7, 2022
Ron Zwanziger, CEO of LumiraDx, a point of care diagnostic company, said that health care is looking to change from a centralized hospital setting to a community setting, according to a press release.
'I'm thrilled to have Troy join the team': Procurement Partners appoints new chief marketing officer
By Andy Nghiem | May 31, 2022
Health care technology company Procurement Partners recently announced that it has appointed Troy Thibodeau, MBA, as its new chief marketing officer.
VPS Healthcare commits to offering pediatric stem cell transplantations to Ukrainian refugees
By David Hutton | May 28, 2022
During the World Economic Forum Annual Meeting in Davos, Switzerland, VPS Healthcare, a UAE-based private health care services platform, announced its commitment to offering 50 pediatric stem cell transplantations to refugees of the Ukraine conflict.
Operating room equipment industry expected to reach $27.4 billion by 2030
By Bob Martin | May 28, 2022
A recent report by Allied Market Research showed that the operating room equipment industry is expected to reach $27.4 billion by 2030, which is a 5.3% compound annual growth rate.
CellBion CEO on agreement with CPDC: 'We are delighted to be working with CPDC and to offer our product to the North American market'
By David Beasley | May 27, 2022
The Centre for Probe Development and Commercialization (CPDC) has entered into a production, manufacturing and supply agreement with a South Korean company, CellBion, for a new treatment of prostate cancer, Lu-177-radiolabelled PSMA (DGUL), according to a news release.
Acorda Therapeutics, Inc. CEO: 'We are delighted to announce these agreements to make INBRIJA available there to people with Parkinson’s disease'
By Karla Florez | May 19, 2022
Acorda Therapeutics, Inc has entered a partnership with Biopas Laboratories to commercialize INBRIJA in Latin America.
GC Corp. president: 'We are thrilled to team up with BioCentriq’s incredibly talented team'
By Karla Florez | Apr 22, 2022
South Korean holding company, GC Corp. has made a definitive arrangement to fully acquire U.S.-based contract development and manufacturing organization, BioCentriq, Inc.
Advanced Clinical opens office in Switzerland to serve ‘pharmaceutical and biotechnology companies in the heart of Europe’
By Karla Florez | Apr 16, 2022
Advanced Clinical, a clinical development and resourcing organization, recently announced it is expanding in Europe with a new office in Zug, Switzerland.
Spectrum Chemical vice president: 'There is an even greater worldwide demand for chemicals whose quality and safety are thoroughly documented' due to COVID-19
By Karla Florez | Mar 22, 2022
Spectrum Chemical Mfg. Corp. has added 12 new products to its bioCERTIFIED quality management system in response to a recent acceleration in global demand.
Chicago-based doctor to lead Advanced Clinical’s International expansion as it 'diversifies global clinical programs and elevates clinical strategy'
By Karla Florez | Mar 15, 2022
Advanced Clinical has invited Chicago-based Dr. Andreas Amrein to join its executive team as senior vice president of Asia-Pacific (APAC) and Japan, and managing director for Europe and Canada.
Seagen, Genmab announce Phase 2 results of squamous cell carcinoma monotheraphy trial
By Trina Thomas | Mar 11, 2022
Phase 2 results of a squamous cell carcinoma of the head and neck monotherapy clinical trail were recently presented by pharmaceutical companies Seagen and Genmab.
'A perfect match': Lincotek to acquire majority stake in Danco Medical
By Andy Nghiem | Mar 8, 2022
An Italian global contract manufacturer expects to grow in the medical field through its deal with Indiana-based Danco Medical.
Herbalife builds new Bangalore, India facility to 'better serve the local market and the world'
By Andy Nghiem | Mar 8, 2022
Los Angeles-based Herbalife Nutrition has opened a new $5 million service center in India.
Flora files for Colombian approval of cannabis products
By George Willis | Mar 7, 2022
Flora Growth Corp. filed 23 cannabinoid-infused food and beverage products with the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in Colombia.
'A step in the right direction': AHF creates global fund target to attack infectious diseases
By Trina Thomas | Mar 5, 2022
The Aids Healthcare Foundation (AHF) has established a global fund to develop forms to treat infectious diseases worldwide.
Organon seeks to 'empower' women with contraceptive product rights acquisition in Asia
By Trina Thomas | Mar 4, 2022
Organon recently acquired the rights to various contraceptive products in China and Macau.
Field Roast partners with Booster Juice to offer a 'convenient plant-based option' in Canada
By Karla Florez | Mar 2, 2022
Greenleaf Foods, SPC’s brand Field Roast began sharing its plant-based creations with consumers in Canada this week through its partnership with Booster Juice.
Humanigen, Cenexi initiate partnership in France
By Art Benavidez | Feb 28, 2022
A clinical-stage biopharmaceutical company has partnered with a major French Contract Development and Manufacturing Organization on master a supply agreement.